- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2018
- Public Summary Document (PSD) July 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2018 PBAC Meeting - Word
Imatinib – July 2018
Imatinib: Tablet 100 mg, Capsule 100 mg, Tablet 400 mg, Capsule 400 mg; Multiple Brands
Last updated
26 October 2018